The mTORC1 activation, defective insulin signaling, lipotoxicity, cytokine production, dysbiosis of the gut and oxidative stress are the main mechanisms of MASLD complications leading to T2DM. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.